Children often contract bacterial infections, with urinary tract infections (UTIs) being one of the most common types.
US health regulators have approved a new antibiotic to treat urinary tract infections, a problem affecting more than 100 million people around the world, mainly women, British pharmaceutical giant GSK ...
The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 years and up, GSK announced on Tuesday. Results of two phase III trials -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results